Cue Biopharma, Inc.CUEEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Cue Biopharma is a clinical-stage biotechnology company focused on developing novel targeted immunotherapies for cancer, autoimmune disorders, and inflammatory diseases. Its proprietary platform enables precise T-cell activity modulation, with core operations in North America and global pharma partnerships to advance lead product candidates through clinical trials.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 6.11% | 2.8M | — | 2024-03-11 |
| BlackRock, Inc. | 4.98% | 2.2M | ▼ -0.22pp | 2024-02-07 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.